Clinical Trial Update: Randomized Control Trial (RCT) of Transarterial Chemoembolization (TACE) Versus TACE and Oral Drug Therapy in the Treatment of Unresectable Hepatocellular Carcinoma [Phase 2, Phase 3]

View source ↗

Summary

An ongoing randomized trial in unresectable hepatocellular carcinoma compares transarterial chemoembolization (TACE) alone versus TACE plus an oral drug therapy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: All India Institute of Medical Sciences | Conditions: Hepatocellular Carcinoma | Phase 2, Phase 3 | Status: UNKNOWN